Funding

Seprify

Switzerland · Climate tech · Biotech

Develops cellulose-based alternative to titanium dioxide for cosmetics, food, and coatings

Visit seprify.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series A€13.4MCambridge Enterprise Ventures — Role not disclosedInter IKEA Group — Role not disclosedKickfund — Role not disclosedUna Terra Early Growth Fund — Role not disclosedZürcher Kantonalbank (ZKB) — Role not disclosed

Investors

Cambridge Enterprise VenturesSeries AInter IKEA GroupSeries AKickfundSeries AUna Terra Early Growth FundSeries AZürcher Kantonalbank (ZKB)Series A

Coverage

Mar 10, 2026Seprify · Series A

Similar companies

Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
iCUREXKagoshima medical-device company developing chitosan hydrogel materials for wound care, including the syringe-delivered Kitosla CX dressing.¥140M · Series A first close: equity and debt
Sourcesseprify.com ↗